New Drug ApprovalFDA Approves TAUKLARIFY, Expanding Tau PET Imaging for Alzheimer’s Diseas... FDA Approves TAUKLARIFY, Expanding Tau PET Imaging for Alzheimer’s Diseas... Read Post »
New Drug ApprovalBMS’s ZENBEXUS Becomes First FDA-Approved CELMoD for RRMM BMS’s ZENBEXUS Becomes First FDA-Approved CELMoD for RRMM Read Post »
New Drug ApprovalChina Approves Ivonescimab Combination for First-Line Squamous NSCLC China Approves Ivonescimab Combination for First-Line Squamous NSCLC Read Post »
New Drug ApprovalUK Becomes First European Country to Authorise Orforglipron UK Becomes First European Country to Authorise Orforglipron Read Post »
New Drug ApprovalEnhertu® Plus Pertuzumab Approved in China as First-Line Treatment for HER... Enhertu® Plus Pertuzumab Approved in China as First-Line Treatment for HER... Read Post »
New Drug ApprovalChina Approves Yochanra (Tinengotinib) for FGFR Inhibitor-Resistant Cholang... China Approves Yochanra (Tinengotinib) for FGFR Inhibitor-Resistant Cholang... Read Post »
New Drug ApprovalMHRA Authorises Rhapsido (Remibrutinib) for Adults with Chronic Spontaneous... MHRA Authorises Rhapsido (Remibrutinib) for Adults with Chronic Spontaneous... Read Post »
New Drug ApprovalFDA Approves TUDRIQEV: First Oncolytic Viral Immunotherapy for PD-1-Refract... FDA Approves TUDRIQEV: First Oncolytic Viral Immunotherapy for PD-1-Refract... Read Post »
New Drug ApprovalModerna Wins FDA Approval for First mRNA Flu Vaccine mFLUSIVA Moderna Wins FDA Approval for First mRNA Flu Vaccine mFLUSIVA Read Post »
New Drug ApprovalReckitt’s Mucinex 12HR Cold & Fever Multi-Symptom Becomes First F... Reckitt’s Mucinex 12HR Cold & Fever Multi-Symptom Becomes First F... Read Post »
New Drug ApprovalEU Approves Expanded Indication for Sanofi’s MenQuadfi in Infants from Si... EU Approves Expanded Indication for Sanofi’s MenQuadfi in Infants from Si... Read Post »
New Drug ApprovalFresenius Kabi Advances Global Biosimilars Portfolio with FDA, EMA Review o... Fresenius Kabi Advances Global Biosimilars Portfolio with FDA, EMA Review o... Read Post »
New Drug ApprovalFDA Approves Pluvicto® for PSMA-Positive Metastatic Hormone-Sensitive Pros... FDA Approves Pluvicto® for PSMA-Positive Metastatic Hormone-Sensitive Pros... Read Post »
New Drug ApprovalUAE Approves ANKTIVA for Bladder Cancer and Advanced Lung Cancer UAE Approves ANKTIVA for Bladder Cancer and Advanced Lung Cancer Read Post »
New Drug ApprovalEU Approves Datroway for Metastatic Triple-Negative Breast Cancer EU Approves Datroway for Metastatic Triple-Negative Breast Cancer Read Post »
New Drug ApprovalEU Approves Pfizer-BioNTech XFG COVID-19 Vaccine for 2026-2027 EU Approves Pfizer-BioNTech XFG COVID-19 Vaccine for 2026-2027 Read Post »
New Drug ApprovalTeleflex Receives FDA Approval for First Freeze-Dried Plasma Product in the... Teleflex Receives FDA Approval for First Freeze-Dried Plasma Product in the... Read Post »
New Drug ApprovalFDA Approves Viatris’ Gwyn Lo Contraceptive Patch for Pregnancy Preve... FDA Approves Viatris’ Gwyn Lo Contraceptive Patch for Pregnancy Preve... Read Post »
New Drug ApprovalFDA Approves Otsuka’s SIMTRIYO as First Triple Reuptake Inhibitor for... FDA Approves Otsuka’s SIMTRIYO as First Triple Reuptake Inhibitor for... Read Post »
New Drug ApprovalFDA Approves LYTENAVA as First Ophthalmic Bevacizumab for Wet AMD FDA Approves LYTENAVA as First Ophthalmic Bevacizumab for Wet AMD Read Post »
New Drug ApprovalFour CHMP Recommendations Could Reshape Care in Psoriasis, AMD, Asthma, and... Four CHMP Recommendations Could Reshape Care in Psoriasis, AMD, Asthma, and... Read Post »
New Drug ApprovalFDA Approves First Subcutaneous Furosemide Autoinjector for HF and CKD FDA Approves First Subcutaneous Furosemide Autoinjector for HF and CKD Read Post »
New Drug ApprovalAstraZeneca’s Etcamah Wins EU Approval for ESR1-Mutated HR-Positive Advan... AstraZeneca’s Etcamah Wins EU Approval for ESR1-Mutated HR-Positive Advan... Read Post »
New Drug ApprovalChina Approves Takeda’s ORZEYFUL for Narcolepsy Type 1 China Approves Takeda’s ORZEYFUL for Narcolepsy Type 1 Read Post »
New Drug ApprovalFDA Approves GSK’s Jideytro for Previously Treated ROS1-Positive Adva... FDA Approves GSK’s Jideytro for Previously Treated ROS1-Positive Adva... Read Post »
New Drug ApprovalMHRA Approves World’s First Lower-Carbon Beclometasone Inhalers for Asthm... MHRA Approves World’s First Lower-Carbon Beclometasone Inhalers for Asthm... Read Post »
New Drug ApprovalIndia’s First Approved Dengue Vaccine: CDSCO Clears Takeda’s QD... India’s First Approved Dengue Vaccine: CDSCO Clears Takeda’s QD... Read Post »
New Drug ApprovalSystImmune Wins First Global Approval for Iza-bren, the First EGFR×HER3 Bi... SystImmune Wins First Global Approval for Iza-bren, the First EGFR×HER3 Bi... Read Post »
New Drug ApprovalEuropean Commission Approves JASCAYD® (Nerandomilast) for Adults with IPF ... European Commission Approves JASCAYD® (Nerandomilast) for Adults with IPF ... Read Post »
New Drug ApprovalNICE Recommends Finerenone for Chronic Heart Failure with Preserved or Mild... NICE Recommends Finerenone for Chronic Heart Failure with Preserved or Mild... Read Post »
New Drug ApprovalFDA Approves Merck’s LIPFENDRA as First Oral PCSK9 Inhibitor FDA Approves Merck’s LIPFENDRA as First Oral PCSK9 Inhibitor Read Post »
New Drug ApprovalEuropean Commission Approves Wegovy® Pill as First Oral GLP-1 Therapy for ... European Commission Approves Wegovy® Pill as First Oral GLP-1 Therapy for ... Read Post »
New Drug ApprovalFDA Grants Full Approval to Retevmo for RET Fusion-Positive Solid Tumors Ac... FDA Grants Full Approval to Retevmo for RET Fusion-Positive Solid Tumors Ac... Read Post »
New Drug ApprovalFDA Approves REVTORPYK for PIK3CA Wild-Type HR+/HER2- Advanced Breast Cance... FDA Approves REVTORPYK for PIK3CA Wild-Type HR+/HER2- Advanced Breast Cance... Read Post »
New Drug ApprovalFDA Approves Weekly LEQEMBI IQLIK Autoinjector for At-Home Initiation of Ea... FDA Approves Weekly LEQEMBI IQLIK Autoinjector for At-Home Initiation of Ea... Read Post »
New Drug ApprovalFDA Approves Merck’s Keytruda Plus Pfizer-Astellas’ Padcev for ... FDA Approves Merck’s Keytruda Plus Pfizer-Astellas’ Padcev for ... Read Post »
New Drug ApprovalSanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena, First Cancer ... Sanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena, First Cancer ... Read Post »
New Drug ApprovalMHRA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis and Progressi... MHRA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis and Progressi... Read Post »
New Drug ApprovalFDA Grants Accelerated Approval to TRUTAKNA for IgA Nephropathy FDA Grants Accelerated Approval to TRUTAKNA for IgA Nephropathy Read Post »
New Drug ApprovalFDA Expands WILATE Prophylaxis Approval to Children Under 6 With von Willeb... FDA Expands WILATE Prophylaxis Approval to Children Under 6 With von Willeb... Read Post »
New Drug ApprovalEU Approves TEPKINLY Plus R2 as New Chemotherapy-Free Option for Follicular... EU Approves TEPKINLY Plus R2 as New Chemotherapy-Free Option for Follicular... Read Post »
New Drug ApprovalMHRA Approves Incyte’s Retifanlimab for Advanced Merkel Cell Carcinom... MHRA Approves Incyte’s Retifanlimab for Advanced Merkel Cell Carcinom... Read Post »
New Drug ApprovalMHRA Conditionally Approves Wegovy for MASH MHRA Conditionally Approves Wegovy for MASH Read Post »
New Drug ApprovalMHRA Authorises Inqlexzo Gemcitabine Delivery System for BCG-Unresponsive H... MHRA Authorises Inqlexzo Gemcitabine Delivery System for BCG-Unresponsive H... Read Post »
New Drug ApprovalEU Approves Novartis’ Itvisma as First Gene Replacement Therapy for C... EU Approves Novartis’ Itvisma as First Gene Replacement Therapy for C... Read Post »
New Drug ApprovalHUTCHMED Secures Third Approved Indication in China for ORPATHYS HUTCHMED Secures Third Approved Indication in China for ORPATHYS Read Post »
New Drug ApprovalFDA Approves CASGEVY for Children Aged 2 and Older With SCD and TDT FDA Approves CASGEVY for Children Aged 2 and Older With SCD and TDT Read Post »
New Drug ApprovalFDA Expands ZORYVE Cream Approval to Children as Young as 2 Years with Plaq... FDA Expands ZORYVE Cream Approval to Children as Young as 2 Years with Plaq... Read Post »
New Drug ApprovalEU Approves Enhertu as First HER2 Tumor-Agnostic Therapy for Advanced Solid... EU Approves Enhertu as First HER2 Tumor-Agnostic Therapy for Advanced Solid... Read Post »
New Drug ApprovalFDA Approves Veligrotug as First Treatment for Active and Chronic Thyroid E... FDA Approves Veligrotug as First Treatment for Active and Chronic Thyroid E... Read Post »
